These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11180191)

  • 1. Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice.
    Nasu R; Matsuo H; Takanaga H; Ohtani H; Sawada Y
    Biopharm Drug Dispos; 2000 May; 21(4):129-38. PubMed ID: 11180191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalepsy induced by calcium channel blockers in mice.
    Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
    Biopharm Drug Dispos; 1998 Mar; 19(2):115-22. PubMed ID: 9533112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine.
    Kariya S; Isozaki S; Masubuchi Y; Suzuki T; Narimatsu S
    Biochem Pharmacol; 1995 Nov; 50(10):1645-50. PubMed ID: 7503767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of catalepsies induced by amiodarone, aprindine and procaine: similarity in conformation of diethylaminoethyl side chain.
    Matsui A; Matsuo H; Takanaga H; Sasaki S; Maeda M; Sawada Y
    J Pharmacol Exp Ther; 1998 Nov; 287(2):725-32. PubMed ID: 9808703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalepsy induced by manidipine, a calcium channel blocker, in mice.
    Haraguchi K; Ito K; Sawada Y; Iga T
    J Pharm Pharmacol; 1996 Apr; 48(4):429-32. PubMed ID: 8794996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy.
    Alcock SJ; Hemsley KM; Crocker AD
    Eur J Pharmacol; 2001 Jul; 424(3):179-87. PubMed ID: 11672560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propiverine-induced Parkinsonism: a case report and a pharmacokinetic/pharmacodynamic study in mice.
    Matsuo H; Matsui A; Nasu R; Takanaga H; Inoue N; Hattori F; Ohtani H; Sawada Y
    Pharm Res; 2000 May; 17(5):565-71. PubMed ID: 10888308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A.
    Tsujikawa K; Dan Y; Nogawa K; Sato H; Yamada Y; Murakami H; Ohtani H; Sawada Y; Iga T
    Biopharm Drug Dispos; 2003 Apr; 24(3):105-14. PubMed ID: 12673668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.
    Assié MB; Dominguez H; Consul-Denjean N; Newman-Tancredi A
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):441-50. PubMed ID: 16947046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy.
    Crocker AD; Hemsley KM
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):573-90. PubMed ID: 11370998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.
    Dall'Igna OP; Tort AB; Souza DO; Lara DR
    J Psychopharmacol; 2005 Jul; 19(4):342-6. PubMed ID: 15982988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.
    Zarrindast MR; Habibi-Moini S
    Gen Pharmacol; 1991; 22(6):1023-6. PubMed ID: 1687392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
    Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
    Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.
    Zhang W; Bymaster FP
    Psychopharmacology (Berl); 1999 Jan; 141(3):267-78. PubMed ID: 10027508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
    Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
    Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.